Please note that all times below refer to British Summer Time (GMT+1)
08:30 – 10:00 hrs | Concurrent Symposia S11-15 & Educational Sessions E11-E12
Room: Hall 3
Chairs: Alex Reymond
S11.1 T2T genomes of multiple individuals
Adam Philippy;
United States
S11.2 Centromere variation and evolution
Glennis Logsdon;
United States
S11.3 The reference genome
Valerie Schneider;
United States
Room: Hall 2
Chairs: Carla Oliveira
S12.1 Patient-derived organs-on-chips as genetic disease models
Donald Ingber;
United States
S12.2 Engineered muscle models of genetic disease
Malte Tiburcy;
Germany
S12.3 Organ-on-a chip as a model for inherited vascular disorders
Valeria Orlova;
Netherlands
Room: Hall 5
Chairs: Zoltan Kutalik
S13.1 Drug target landscape of immune traits
Julian Knight;
United Kingdom
S13.2 Strategies for the identification of causal variants
Nicole Sorenzo;
Italy
S13.3 The long journey from GWAS SNPs to drug target genes
Brent Richards;
Canada
Room: Lomond Auditorium
Chairs: Cristina Rodriguez-Antona
S14.1 Hereditary renal cell carcinoma syndromes
Eamonn R. Maher;
United Kingdom
S14.2 The genetic evolution of Renal Cell Carcinoma
Samra Turajlic;
United Kingdom
S14.3 Molecular genetics and precision medicine in renal cancer
James Brugarolas;
United States
Room: M1
Chairs: Thomas Eggermann
S15.1 Regulation of gene expression in human placenta and its disturbances
David Monk;
United Kingdom
S15.2 Placental dysfunction and pregnancy outcome: an interdisciplinary challenge (view from a prenatal medicine)
Karl Oliver Kagan;
Germany
S15.3 Role of the placenta in guiding fetal development and metabolism
Emin Maltepe;
United States
Room: Clyde Auditorium
Chairs: Kelly Ormond
E11.1 Sex, gender, and pedigrees in clinical genetics: What to record, how to record it, and why
Jehannine Austin;
Canada
E11.2 Gender Affirming Genetics Practices
Kimberly Zayhowski;
United States
Room: Hall 1
Chairs: Karin Writzl and Hülya Kayserili
E12.1 RASopathies: clinical manifestations and therapy
Martin Zenker;
Germany
E12.2 RASopathies: pathways, genes and mechanisms
Marco Tartaglia;
Italy
08:30 – 10:00 hrs | Corporate Satellites
10:00 – 10:30 hrs | Coffee Break, Exhibition, Poster Viewing
10:30 – 12:00 hrs | Concurrent Sessions C16-C23 from submitted abstracts
12:00 – 13:00 hrs | Lunch Break, Exhibition, Poster Viewing
12:15 – 13:15 hrs | ESHG General Assembly | Room M1
12:00 – 13:00 hrs | Corporate Satellites
13:00 – 14:00 hrs | Poster Viewing with Authors – Group C
14:00 – 15:30 hrs | Workshops W12-W18
Room: Hall 3
More information will be available at the beginning of 2023.
Room: Clyde Auditorium
More information will be available at the beginning of 2023.
Room: Hall 2
More information will be available at the beginning of 2023.
Room: Hall 5
More information will be available at the beginning of 2023.
Room: Lomond Auditorium
More information will be available at the beginning of 2023.
Room: M1
More information will be available at the beginning of 2023.
Room: Hall 1
More information will be available at the beginning of 2023.
14:15 – 15:45 hrs | Corporate Satellites
15:30 – 15:45 hrs | Fruit Break, Exhibition, Poster Viewing
15:45 – 16:45 hrs | Poster Viewing with Authors – Group D
17:00 – 18:30 hrs | Concurrent Symposia S16-S20 & Educational Session E13-E14
Room: Hall 3
Chairs: TBA
S16.1 Systematically editing the human genome at scale
Greg Findlay;
United Kingdom
S16.2 Novel high throughput functional genomics approaches
Jozef Gecz
Australia
S16.3 Functional characterization of genetic variation affecting expression
Tuuli Lappalainen;
Sweden
Room: Clyde Auditorium
Chairs: Christian Gilissen and Rob Taylor
S17.1 Diagnostic applications of long-read RNAseq
Mina Ryten;
United Kingdom
S17.2 Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing
Ira Deveson;
Australia
S17.3 Haplotype-resolved diverse human genomes and integrated analysis of structural variation
Joris Vermeesch;
Belgium
Room: Hall 5
Chairs: Juliana Miranda Cerqueira and Rita Matos
S18.1 Training researchers to engage with patients: the importance of co-creation
Anne-Charlotte Fauvel;
Belgium
S18.2 Engaging patients in clinical trials endpoints: A Gaucher Disease Registry perspective
Tanya Collin-Histed;
United Kingdom
S18.3 Inclusive genetics research with people with intellectual disability
Elizabeth Palmer;
Australia
Room: M1
Chairs: Karoline Kuchenbaecker and Rhys Dore
S19.1 The spatial structure of populations and traits
Mashaal Sohail;
Mexico
S19.2 tbc
Eimear Kenny;
United States
S19.3 BioBank Japan and what we have learnt so far
Yukinori Okada;
Japan
Room: Hall 1
Chairs: TBA
S20.1 Susceptibility to pediatric cancer
William D Foulkes;
Canada
S20.2 TBA
S20.3 Surviving to cancer and therapy from the paediatric age
Ruben van Boxtel;
Netherlands
Room: Hall 2
Chairs: Alexander Hoischen
E13.1 Naked-mole rat and aging
Vera Gorbunova;
Untited States
E13.2 Evolution of somatic mutation rates
Alex Cagan;
Untited Kingdom
Room: Lomond Auditorium
Chairs: Alexandre Reymond
E14.1 Enhancer-promoter interactions
Luca Giorgetti;
Switzerland
E14.2 Resolution of regulatory conflicts through genome 3D-restructuring
Michael Robson;
Germany
20:00 | ESHG Networking Evening (at own expense)
*An asterisk indicates that the presenter is an Early Career Award Candidate
Note that the programme is subject to change, and will be updated continuously up to the conference